Drug intelligence / Profile preview

TheraCour Cell Therapy (Parkinson's)

Development stage
Preclinical
Lead developer
AllExcel
Modality
Hydrogel Systems → Drug Delivery Systems, Cell Therapies
Administration
Intracerebral
01

Overview

TheraCour Cell Therapy (Parkinson's) is a preclinical cell replacement therapy being developed by AllExcel for the treatment of Parkinson's disease. The therapy involves the transplantation of factory-manufactured, HLA-matched dopaminergic cells designed to replace the substantia nigra neurons lost during the progression of the disease. To enhance cell survival and protect against host immune responses, the cells are encapsulated in AllExcel's proprietary TheraCour gel, a micelle-forming, self-assembling polymeric material. This approach aims to provide a curative treatment by restoring dopamine production in the brain while minimizing the need for immunosuppression.

Other names
AllExcel Parkinson's cell therapyTheraCour-Parkinson'sAllExcel-substantia nigra cells-cell therapy (HLA-matched, factory-manufactured cells encapsulated in TheraCour gel)-Parkinson's Disease

Beyond the preview

Go deeper on TheraCour Cell Therapy (Parkinson's).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TheraCour Cell Therapy (Parkinson's).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call